Medical Microbiology I - Lecture12

41
MEDICAL MICROBIOLOGY I Lesson 12 Lesson 12 Enterobacteriaceae Part II

description

Notes

Transcript of Medical Microbiology I - Lecture12

  • MEDICAL MICROBIOLOGY I

    Lesson 12 Lesson 12

    Enterobacteriaceae Part II

  • Salmonella

    Gram negative rods, motile, and facultatively

    anaerobic

    Oxidase negative, catalase positive, KCN

    negative, usually citrate positive and H2S negative, usually citrate positive and H2S

    positive, ferments carbohydrates

    Most salmonellae are parasites of man, animals

    (pigs, cows, goats, etc) and birds (hens, duck,

    etc)

    S. typhi and S. paratyphi are parasites of man

    only

  • Salmonella

  • Salmonella on CLED agar

  • Pathogenesis and Immunity

    After ingestion and passage through the

    stomach, salmonellae are able to invade and

    replicate in the M (microfold) cells located in

    Peyers patches of the terminal portion of the Peyers patches of the terminal portion of the

    small intestine

    These cells typically transport foreign antigens

    to the underlying macrophages for clearance

  • Pathogenesis and Immunity

    Two separate type III secretion systems

    mediate the initial invasion into the intestinal

    mucosa (Salmonella pathogenicity island 1

    [SPI-1] and subsequent systemic disease [SPI-[SPI-1] and subsequent systemic disease [SPI-

    2])

    Binding to M cells is mediated by species-

    specific fimbriae

  • Pathogenesis and Immunity

    The SPI-1 secretion system then introduces

    Salmonella-secreted invasion proteins (Sips or

    Ssps) into the M cells, resulting in

    rearrangement of the host cell actin with rearrangement of the host cell actin with

    subsequent membrane ruffling

    The ruffled membrane surround and engulf

    salmonellae, leading to intracellular replication

    in the phagosome with subsequent host cell

    death and spread to adjacent epithelial cells

    and lymphoid tissue

  • Pathogenesis and Immunity

    The inflammatory response confines the infection to the GIT, mediates the release of prostaglandins, and stimulates cAMP and active fluid secretion

    Salmonella species are also protected from stomach acid and the acid pH of the phagosome by an acid tolerance response (ATR) gene

    Catalase and superoxide dismutase are other factors that protect the bacteria from intracellular killing

  • Epidemiology

    Salmonella can colonise virtually all animals including poultry, reptiles, livestock, rodents, domestic animals, birds, and humans

    Animal-animal spread and the use of Animal-animal spread and the use of Salmonella-contaminated animal feeds maintain an animal reservoir

    S. typhi and S. paratyphi are highly adapted to humans and do not cause disease in non-human hosts

  • Epidemiology

    Transmission: contaminated food products

    (e.g. poultry, eggs, dairy products and foods

    prepared on contaminated work surfaces),

    faecal-oral route (especially in children)faecal-oral route (especially in children)

    The infectious dose for S. typhi infections is

    low, so person-person spread is common

    Large inoculum is required for symptomatic

    disease to develop with other Salmonella sp.

  • Epidemiology

    The infectious dose is lower for people at high

    risk for disease because of age,

    immunosuppression or underlying disease

    (e.g. leukaemia, lymphoma, sickle cell (e.g. leukaemia, lymphoma, sickle cell

    disease), or reduced gastric acidity

  • Clinical Diseases

    1. Enteritis

    The most common form of salmonellosis

    Symptoms generally appear 6 - 48 hours after the consumption of contaminated food or the consumption of contaminated food or water, with the initial presentation consisting of nausea, vomiting, and non-bloody diarrhoea

    Fever, abdominal cramps, myalgias, and headache are also common

    Symptoms can persist from 2 days to 1 week before spontaneous resolution

  • Clinical Diseases

    2. Septicaemia

    All Salmonella species can cause bacteraemia, although infections with S. cholerasuis, S. paratyphi and S. typhi more commonly lead to bacteraemia phasebacteraemia phase

    The risk of Salmonella bacteraemia is higher in paediatric and geriatric patients as well as patients with AIDS

    Symptoms: Gram negative bacteraemias; 10% localised suppurative infections, such as osteomyelitis, endocarditis, and arthritis

  • Clinical Diseases

    3. Enteric fever

    S. typhi produce febrile illness - typhoid fever

    Mild: S. paratyphi A, S. schottimuelleri, and S.

    hirschfeldii - paratyphoid feverhirschfeldii - paratyphoid fever

    Bacteria pass through the cell lining the

    intestines and are engulfed by macrophages -

    replicated (liver, spleen, and bone marrow)

    Symptoms: fever, headache, myalgias, malaise,

    and anorexia, persist for a week or longer

  • Clinical Diseases

    4. Asymptomatic colonisation

    The species of Salmonella responsible for

    causing typhoid and paratyphoid fevers are

    maintained by human colonisationmaintained by human colonisation

    Chronic colonisation for more than 1 year after

    symptomatic disease develops in 1 - 5% of

    patients, the gall bladder being the reservoir in

    most patients

  • Shigella

    Gram negative rods, aerobic and facultatively

    anaerobic, non-motile, mostly catalase

    negative, oxidase negative and ferment

    carbohydrates mostly without gas, citrate and carbohydrates mostly without gas, citrate and

    KCN negative

    Shigellae are found in the intestinal tract of

    man

    They are strict human parasites

  • Shigella

  • Shigella Infection

  • Pathogenesis and Immunity

    Shigella cause disease by invading and replicating in cells lining the colonic mucosa

    Structural gene proteins mediate the adherence of the organisms to the cells as well adherence of the organisms to the cells as well as their invasion, intracellular replication, and cell-cell spread

    Shigella species appear unable to attach to differentiated mucosa cells; rather, they first attach to and invade the M cells located in Peyers patches

  • Pathogenesis and Immunity

    The type III secretion system mediates

    secretion of four proteins (IpaA, IpaB, IpaC,

    IpaD) into epithelial cells and macrophages

    Shigella are able to lyse the phagocytic Shigella are able to lyse the phagocytic

    vacuole and replicate in the host cell

    cytoplasm; unlike Salmonella, which replicate

    in the vacuole

  • Pathogenesis and Immunity

    With the rearrangement of actin filaments in

    the host cells, the bacteria are propelled

    through the cytoplasm to adjacent cells, where

    cell-cell passage occurs - protected from cell-cell passage occurs - protected from

    immune-mediated clearance

    Shigella survive phagocytosis by inducing

    apoptosis - release of interleukin-1, resulting

    in the attraction of polymorphonuclear

    leukocytes into the infected cells - destabilises

    the integrity of the intestinal wall

  • Pathogenesis and Immunity

  • Pathogenesis and Immunity

    S. dysenteriae produce an exotoxin, Shiga toxin

    Like the toxin produced by EHEC, the Shiga toxin has one A subunit and five B subunits

    The B subunits bind to a host cell glycolipid The B subunits bind to a host cell glycolipid (Gb3) and facilitate transfer of the A subunit into the cell

    The A subunit cleaves 28s rRNA in the 60s ribosomal subunit, thereby preventing the binding of aminoacyl-transfer RNA and disrupting protein synthesis

  • Epidemiology

    4 species consisting of more than 45 O

    antigen-based serogroups have been

    described: S. dysenteriae, S. flexneri, S. boydii,

    and S. sonneiand S. sonnei

    S. sonnei is the most common cause of

    shigellosis in the industrial world, and S.

    flexneri is the most common cause in

    developing countries

  • Epidemiology

    Shigellosis is primarily a paediatric disease; 70% of all infections occur in children younger than 15 years

    Endemic disease in adults is common in male Endemic disease in adults is common in male homosexuals and in household contacts of infected children

    Epidemic outbreaks of disease occur in daycare centers, nurseries, and custodial institutions

  • Epidemiology

    Transmission: faecal-oral routes, primarily by

    people with contaminated hands and less

    commonly in water or food

    Because as few as 200 bacilli can establish Because as few as 200 bacilli can establish

    disease, shigellosis spreads rapidly in

    communities where sanitary standards and

    the level of personal hygiene are low

  • Clinical Diseases

    Symptoms: abdominal cramps, diarrhoea,

    fever, and bloody stools

    Clinical signs and symptoms of the disease

    appear 1 - 3 days after bacilli are ingested appear 1 - 3 days after bacilli are ingested

    The bacilli initially colonise the small intestine

    and begin to multiply within the first 12 hours

    Abundant pus, neutrophils, erythrocytes, and

    mucus in stool

  • Clinical Diseases

    Infection is generally self-limited, although

    antibiotic treatment is recommended to

    reduce the risk of secondary spread to family

    members and other contactsmembers and other contacts

    Asymptomatic colonisation of the organism in

    the colon develops in a small number of

    patients and represents a persistent reservoir

    for infection

  • Other Enterobacteriaceae

    1. Klebsiella

    Members of the genus Klebsiella have a

    prominent capsule that is responsible for the

    mucoid appearance of isolated colonies and mucoid appearance of isolated colonies and

    the enhanced virulence of the organisms in

    vivo

    K. pneumoniae can cause community-

    acquired primary lobar pneumonia

  • Other Enterobacteriaceae

    Alcoholics and people with compromised pulmonary function are at increased risk for pneumonia because of their inability to clear aspirated oral secretions from the lower respiratory tractrespiratory tract

    Pneumonia due to Klebsiella species frequently involves necrotic destruction of alveolar spaces, formation of cavities, and the production of blood-tinged sputum

  • Other Enterobacteriaceae

    2. Proteus

    Infection of the urinary tract with Proteusmirabilis is the most common disease produced by this genusproduced by this genus

    P. mirabilis produces large quantities of ureases, which splits urea into carbon dioxide and ammonia

    This process raises the urine pH and facilitates the formation of renal stones

  • Other Enterobacteriaceae

    The increased alkalinity of the urine is also

    toxic to uroepithelium

    Despite the serologic diversity of these

    organisms, infection has not been associated organisms, infection has not been associated

    with any specific serogroup

    The pili on P. mirabilis may decrease its

    virulence by enhancing the phagocytosis of

    the bacilli, unlike E. coli

  • Laboratory Diagnosis

    Specimens: sterile specimens such as CSF and tissue collected at surgery should be cultured on blood agar (non-selective media)

    Specimens: contaminated specimens such as Specimens: contaminated specimens such as sputum and faeces should be cultured on MacConkey and eosin methylene blue (EMB) agar

    This is to separate lactose fermenting from non-lactose fermenting strains

  • Laboratory Diagnosis

    Highly selective or organism-specific media are

    useful for the recovery of organisms in stool,

    whereas abundance of normal flora can

    obscure the presence of these important obscure the presence of these important

    pathogens

    Cold enrichment permits the growth of

    Yersinia but inhibits or kills other organisms

  • Laboratory Diagnosis

    Biochemical identification

    Triple sugar iron agar, indole, methyl red, Voges-Poskauer, citrate, malonate, urease,

    pheulalanine deaminase, orthonitrophenyl--D-galactopyranoside test ( -galactosidase test), galactopyranoside test ( -galactosidase test), arabinose fermentation

    Serologic classification

    Serotyping specific pathogenic strains: usefulness of this procedure is limited

  • Treatment, Prevention and Control

    Antibiotic therapy must be guided by in vitro susceptibility test results and clinical experience

    Some organisms, such as E. coli and P. Some organisms, such as E. coli and P. mirabilis are susceptible to many antibiotics, other can be highly resistant

    Susceptible organisms exposed to sub-therapeutic concentrations of antibiotics in a hospital setting can rapidly develop resistance

  • Treatment, Prevention and Control

    Symptomatic relief, but not antibiotic

    treatment, is usually recommended for

    patients with E. coli or Salmonella

    gastroenteritis because antibiotics can prolong gastroenteritis because antibiotics can prolong

    the faecal carriage of these organisms or

    increase the risk of secondary complications

    (e.g. HUS with EHEC infections in children)

  • Treatment, Prevention and Control

    Avoid risk factors:

    The unrestricted use of antibiotics that can select

    for resistant bacteria

    The performance of procedures that traumatise The performance of procedures that traumatise

    mucosal barriers without prophylactic antibiotic

    coverage

    The use of urinary catheters

    Exogenous infection with Enterobacteriaceae

    is theoretically easier to control

  • Treatment, Prevention and Control

    These bacteria are ubiquitous in poultry and eggs

    Shigella organisms are predominantly transmitted in young children, but it is difficult to interrupt the faecal-hand-mouth to interrupt the faecal-hand-mouth transmission responsible for spreading the infection in this population

    Prevention and control: education and introduction of appropriate infection-control procedure (e.g. hand washing, proper disposal of soiled diapers and linens)

  • Treatment, Prevention and Control

    Vaccination with formalin-killed Yersinia pestis has proved effective for people at high risk

    Chemoprophylaxis with tetracycline has also proved useful for people in close contact with a patient with pneumonic plaguepatient with pneumonic plague

    Improvement in the live, attenuated S. typhi vaccines gives significant protection, persist for up to 5 years

    Vaccination with purified Vi antigen (the polysaccharide) capsular antigen of S. typhi associated with virulence), are also protective